| 产品详情 |
| Edit |   |
| Product Name | Recombinant Human LILRB1/CD85j/ILT2 Fc Chimera Protein, CF |
| Description | Purity >90%, by SDS-PAGE under reducing conditions and visualized by silver stain. MW (observed): 106 kDa, reducing conditions. MW (theoretical): 73.8 kDa (monomer). The Recombinant Human LILRB1/CD85j/ILT2 Fc Chimera Protein from R&D Systems is derived from NS0. The Recombinant Human LILRB1/CD85j/ILT2 Fc Chimera Protein has been validated for the following applications: Bioactivity. |
| Size | 50 ug |
| Concentration | n/a |
| Applications | Bioactivity |
| Other Names | CD85 antigen-like family member J, CD85J, CD85j antigen, Ig-like transcript 2, ILT2, ILT-2, ILT2FLJ37515, Immunoglobulin-like transcript 2, leukocyte Ig-like receptor-1, Leukocyte immunoglobulin-like receptor 1, leukocyte immunoglobulin-like receptor subfamily B member 1, leukocyte immunoglobulin-like receptor subfamily B member 1 soluble isoform, leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), LIR1, LIR1LIR-1MIR-7CD85MIR7CD85 antigen, member 1, MIR7, Monocyte/macrophage immunoglobulin-like receptor 7 |
| Gene, Accession, CAS # | LILRB1, Gene ID: 10859, Accession: Q8NHL6 |
| Catalog # | 2017-T2-050 |
| Price | |
| Order / More Info | Recombinant Human LILRB1/CD85j/ILT2 Fc Chimera Protein, CF from R&D SYSTEMS, INC. |
| Product Specific References | PubMed: 21248264, 22144141, 23348966, 27145901 |
| 产品资料 |
|
|